MetaADEDB 2.0 @ LMMD
Dotatate lutenium Lu-177
(MXDPZUIOZWKRAA-PRDSJKGBSA-K)
Structure
SMILES
NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)O)[C@H](O)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])Cc1c[nH]c2c1cccc2.[177Lu+3]
Type(s)
Approved; Investigational
Molecular Formula:
C65H87LuN14O19S2
Molecular Weight:
1609.540
Log P:
-4.1101
Hydrogen Bond Acceptor:
34
Hydrogen Bond Donor:
14
TPSA:
556.55
CAS Number(s):
437608-50-9
Synonym(s)
1.
Dotatate lutenium Lu-177
2.
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+)
3.
Lutathera
External Link(s)
PubChem Compound132274234
76966897
121225499
DrugBankDB13985
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 3US FAERS
2Prothrombin time ratio decreasedFAERS: 3US FAERS
3AscitesFAERS: 2US FAERS
4Peripheral swellingFAERS: 2US FAERS
5VomitingFAERS: 2US FAERS
6AlopeciaFAERS: 1US FAERS
7Atrial FibrillationFAERS: 1US FAERS
8Back PainFAERS: 1US FAERS
9Blood count abnormalFAERS: 1US FAERS
10Bone painFAERS: 1US FAERS
11ConstipationFAERS: 1US FAERS
12Disease ProgressionFAERS: 1US FAERS
13FatigueFAERS: 1US FAERS
14FlushingFAERS: 1US FAERS
15Malignant neoplasm progressionFAERS: 1US FAERS
16Product use in unapproved indicationFAERS: 1US FAERS
17Skin reactionFAERS: 1US FAERS
18T-Cell LymphomaFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120264

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.